Norman Wolmark, MD Professor and Chairman Department of Human Oncology Allegheny General Hospital Professor, Drexel University College of Medicine Chairman, National Surgical Adjuvant Breast and Bowel Project Pittsburgh, Pennsylvania
Faculty featured on accompanying 5-CD audio patient education program
	George A Fisher, MD, PhD Associate Professor of Medicine Stanford University School of Medicine; Director, Clinical Trials Office, Stanford University Cancer Center Palo Alto, California		Neal J Meropol, MD Director, Gastrointestinal Cancer Program; Director, Gastrointestinal Tumor Risk Assessment Program Divisions of Medical Science and Population Science Fox Chase Cancer Center Philadelphia, Pennsylvania
	Axel Grothey, MD Senior Associate Consultant Department of Medical Oncology, Mayo Clinic Rochester, Minnesota		Leonard B Saltz, MD Professor of Medicine Weill Medical College of Cornell University; Attending Physician Colorectal Disease Management Team Leader, Memorial Sloan- Kettering Cancer Center New York, New York
	John L Marshall, MD Chief, Hematology and Oncology Director of Developmental Therapeutics and GI Oncology Lombardi Comprehensive Cancer Center, Georgetown University Washington, DC		Robert A Wolff, MD Associate Professor of Medicine Deputy Chairman for Clinical Affairs Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas

 

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME/CNE activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process:

Lisa Aiello-Laws, RN, MNS, APN,C, AOCNS, John Brebner, Regina Seery Cunningham, PhD, RN, AOCN, Melanie Elder, Karen Green, MD, Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Chris Thomson, MD, MS, Jean Treacy, RN, CS, AOCNP, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech BioOncology. Research To Practice receives education grants from Abraxis BioScience, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health Inc, GPC Biotech, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Fisher — Consulting Fees: Genentech BioOncology, Pfizer Inc, Sanofi-Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Roche Laboratories Inc. Dr Grothey — Consulting Fees: Amgen Inc, Bristol-Myers Squibb Company, Genentech BioOncology, Roche Laboratories Inc, Sanofi-Aventis. Dr Marshall — Consulting Fees and Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Amgen Inc, Bristol-Myers Squibb Company, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis. Dr Meropol — Consulting Fees: Amgen Inc, Genentech BioOncology, Pfizer Inc; Contracted Research: Genentech BioOncology. Dr Saltz — Consulting Fees: Access Pharmaceuticals Inc, Bayer Pharmaceuticals Corporation, Genentech BioOncology, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, YM BioScience Inc. Dr Wolff — No financial interests or affiliations to disclose. Dr Wolmark — No financial interests or affiliations to disclose.

---

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.

 

Table of Contents

Top of Page